Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2001 Mar;77(905):177–180. doi: 10.1136/pmj.77.905.177

Sarcoidosis 2001

D James 1
PMCID: PMC1741943  PMID: 11222825

Abstract

In every decade, sarcoidosis makes a chameleon-like change so its profile needs to be updated. It was first recognised as a dermatological curiosity which evolved into a multisystem disorder with bone cysts, uveitis, and intrathoracic involvement. New dimensions were uncovered by biochemistry and immunology, bringing it still nearer the elusive enigma, namely the cause of sarcoidosis. Aetiology includes an understanding of a genetic predisposition and environmental trigger factors. What was left undone in the 20th century will become evident in the 21st century with more sophisticated technology. Likewise, conventional treatments of the past will be superseded by cytokines and other magic bullets of the millennium.


Keywords: anergy; apoptosis; homoeostasis; cytokines

Full Text

The Full Text of this article is available as a PDF (87.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong L., Foley N. M., Millar A. B. Inter-relationship between tumour necrosis factor-alpha (TNF-alpha) and TNF soluble receptors in pulmonary sarcoidosis. Thorax. 1999 Jun;54(6):524–530. doi: 10.1136/thx.54.6.524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hashimoto S., Nakayama T., Gon Y., Hata N., Koura T., Maruoka S., Matsumoto K., Hayashi S., Abe Y., Horie T. Correlation of plasma monocyte chemoattractant protein-1 (MCP-1) and monocyte inflammatory protein-1alpha (MIP-1alpha) levels with disease activity and clinical course of sarcoidosis. Clin Exp Immunol. 1998 Mar;111(3):604–610. doi: 10.1046/j.1365-2249.1998.00519.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Iyonaga K., Suga M., Ichiyasu H., Yamamoto T., Hiraga Y., Ando M. Measurement of serum monocyte chemoattractant protein-1 and its clinical application for estimating the activity of granuloma formation in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1998 Sep;15(2):165–172. [PubMed] [Google Scholar]
  4. James D. G. The sarcoidosis movement and its personalities. J Med Biogr. 1995 Aug;3(3):148–160. doi: 10.1177/096777209500300305. [DOI] [PubMed] [Google Scholar]
  5. Kawakami K., Owan I., Kaneshima H., Saito A. Type 1-like helper T cell lines responsive to autologous peripheral blood monocytes established from two patients with sarcoidosis. Sarcoidosis. 1995 Sep;12(2):111–117. [PubMed] [Google Scholar]
  6. Kodama N., Yamaguchi E., Hizawa N., Furuya K., Kojima J., Oguri M., Takahashi T., Kawakami Y. Expression of RANTES by bronchoalveolar lavage cells in nonsmoking patients with interstitial lung diseases. Am J Respir Cell Mol Biol. 1998 Apr;18(4):526–531. doi: 10.1165/ajrcmb.18.4.2868. [DOI] [PubMed] [Google Scholar]
  7. Kunitake R., Kuwano K., Miyazaki H., Hagimoto N., Nomoto Y., Hara N. Apoptosis in the course of granulomatous inflammation in pulmonary sarcoidosis. Eur Respir J. 1999 Jun;13(6):1329–1337. doi: 10.1183/09031936.99.13613389. [DOI] [PubMed] [Google Scholar]
  8. Luster A. D. Chemokines--chemotactic cytokines that mediate inflammation. N Engl J Med. 1998 Feb 12;338(7):436–445. doi: 10.1056/NEJM199802123380706. [DOI] [PubMed] [Google Scholar]
  9. Martinetti M., Tinelli C., Kolek V., Cuccia M., Salvaneschi L., Pasturenzi L., Semenzato G., Cipriani A., Bartova A., Luisetti M. "The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries. Am J Respir Crit Care Med. 1995 Aug;152(2):557–564. doi: 10.1164/ajrccm.152.2.7633707. [DOI] [PubMed] [Google Scholar]
  10. Mishra B. B., Poulter L. W., Janossy G., James D. G. The distribution of lymphoid and macrophage like cell subsets of sarcoid and Kveim granulomata: possible mechanism of negative PPD reaction in sarcoidosis. Clin Exp Immunol. 1983 Dec;54(3):705–715. [PMC free article] [PubMed] [Google Scholar]
  11. Moodley Y. P., Dorasamy T., Venketasamy S., Naicker V., Lalloo U. G. Correlation of CD4:CD8 ratio and tumour necrosis factor (TNF)alpha levels in induced sputum with bronchoalveolar lavage fluid in pulmonary sarcoidosis. Thorax. 2000 Aug;55(8):696–699. doi: 10.1136/thorax.55.8.696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Raghu G., Johnson W. C., Lockhart D., Mageto Y. Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study. Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 1):1061–1069. doi: 10.1164/ajrccm.159.4.9805017. [DOI] [PubMed] [Google Scholar]
  13. Reiser H., Stadecker M. J. Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases. N Engl J Med. 1996 Oct 31;335(18):1369–1377. doi: 10.1056/NEJM199610313351807. [DOI] [PubMed] [Google Scholar]
  14. Roman J., Jeon Y. J., Gal A., Perez R. L. Distribution of extracellular matrices, matrix receptors, and transforming growth factor-beta 1 in human and experimental lung granulomatous inflammation. Am J Med Sci. 1995 Mar;309(3):124–133. doi: 10.1097/00000441-199503000-00002. [DOI] [PubMed] [Google Scholar]
  15. Takemoto Y., Sakatani M., Takami S., Tachibana T., Higaki J., Ogihara T., Miki T., Katsuya T., Tsuchiyama T., Yoshida A. Association between angiotensin II receptor gene polymorphism and serum angiotensin converting enzyme (SACE) activity in patients with sarcoidosis. Thorax. 1998 Jun;53(6):459–462. doi: 10.1136/thx.53.6.459. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES